The American Journal of Medicine
Volume 120, Issue 5 , Pages 461.e11-461.e17, May 2007

Hyponatremia in Marathon Runners due to Inappropriate Arginine Vasopressin Secretion

  • Arthur J. Siegel, MD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Joseph G. Verbalis, MD

      Affiliations

    • Department of Medicine, Georgetown University Medical Center, Washington, DC
  • ,
  • Stephen Clement, MD

      Affiliations

    • Department of Medicine, Georgetown University Medical Center, Washington, DC
  • ,
  • Jack H. Mendelson, MD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Nancy K. Mello, PhD

      Affiliations

    • Department of Medicine, McLean Hospital, Belmont, Mass
    • Harvard Medical School, Boston, Mass
  • ,
  • Marvin Adner, MD

      Affiliations

    • Metrowest Medical Center, Framingham, Mass
  • ,
  • Terry Shirey, PhD

      Affiliations

    • Nova Biomedical Inc, Waltham, Mass
  • ,
  • Julie Glowacki, PhD

      Affiliations

    • Department of Orthopedics, Brigham and Women's Hospital
    • Harvard Medical School, Boston, Mass
  • ,
  • Elizabeth Lee-Lewandrowski, PhD

      Affiliations

    • Division of Laboratory Medicine, Department of Pathology, Massachusetts General Hospital, Boston, Mass.
    • Harvard Medical School, Boston, Mass
  • ,
  • Kent B. Lewandrowski, MD

      Affiliations

    • Metrowest Medical Center, Framingham, Mass
    • Harvard Medical School, Boston, Mass
    • Corresponding Author InformationRequests for reprints should be addressed to Kent B. Lewandrowski, MD, Clinical Chemistry, Gray 5, Massachusetts General Hospital, Fruit Street, Boston, MA 02114.

Abstract 

Purpose

Exercise-associated hyponatremia (EAH), as defined by a blood sodium concentration [Na+] less than 135 mmol/L, may lead to hypotonic encephalopathy with fatal cerebral edema. Understanding the pathogenetic role of antidiuresis may lead to improved strategies for prevention and treatment.

Methods

Normonatremic marathon runners were tested pre- and post-race for creatine kinase, interleukin-6, cortisol, prolactin, and arginine vasopressin. Similar testing also was carried out in runners with encephalopathy caused by EAH, including 2 cases with fatal cerebral edema.

Results

Normonatremic runners (n = 33; 2001) with a mean 3% decrease in body weight showed a 40-fold increase in interleukin-6 (66.6 ± 11.9 pg/mL from 1.6 ± 0.5 pg/mL, P = .001), which was significantly correlated with increases in creatine kinase (r = 0.88, P = <.0001), cortisol (r = 0.70, P = .0003), and prolactin (r = 0.67, P <.007), but not arginine vasopressin (r = 0.44, P = .07). Collapsed runners with EAH (n = 22; 2004) showed a mean blood urea nitrogen less than 15 mg/dL with measurable plasma levels of arginine vasopressin (>0.5 pg/mL) in 43% of cases. Two marathon runners with fatal cerebral edema additionally showed less than maximally dilute urines (>100 mmol/kg/H2O) and urine [Na+] greater than 25 mEq/L.

Conclusions

Cases of EAH fulfill the essential diagnostic criteria for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Runners with hypotonic encephalopathy at subsequent races were treated with intravenous hypertonic (3%) saline on the basis of this paradigm, which resulted in rapid clinical improvement without adverse effects. Release of muscle-derived interleukin-6 may play a role in the nonosmotic secretion of arginine vasopressin, thereby linking rhabdomyolysis to the pathogenesis of EAH.

Keywords: Arginine vasopressin, Exercise-associated hyponatremia, Hypertonic (3%) saline, Interleukin-6, Rhabdomyolysis, Syndrome of inappropriate antidiuretic hormone secretion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants KO5-DA00064, KO5-DA00101, and POI-DA14528 from National Institute on Drug Abuse, and by grant M01-RR 020359 from the National Center for Research Resources, National Institutes of Health.

PII: S0002-9343(07)00167-2

doi:10.1016/j.amjmed.2006.10.027

The American Journal of Medicine
Volume 120, Issue 5 , Pages 461.e11-461.e17, May 2007